Olympus quality fixes are being accelerated as the company moves to close gaps highlighted in FDA notices from 2022, 2023 and a fresh October 2025 notice.

Abbott receives regulatory clearance to sell its UltiSynq defibrillation lead in the US and EU, delivering conduction system pacing to treat patients at risk of

Labcorp buys Millennium Health's drug testing division, expanding operations across a broader area with specialized toxicology services.

Natera appoints Solomon Moshkevich as CEO, leveraging his 15-year expertise in molecular residual disease testing and cell-free DNA tests.

The FDA is seeking public input on robotic surgery safety rules for autonomous or remote-controlled systems, addressing key risks in patient safety and technolo

Siemens splits off diagnostics business to form Olyrian Diagnostics, focusing on lab diagnostic products.

Medicare cuts billions in 340B payments and expands site-neutral rates starting 2027.

Boston Scientific partners with Blackstone to fund its miniaturized heart pump, with up to $455 million in financing.

Latest in cardiology with advancements in TAVR and renal denervation, reshaping cardiovascular treatment strategies.

Doctors, AI makers, and hospitals share liability risks in new guidelines to prevent patient harm from clinical AI tools as adoption grows.